Myriad Genetics (NASDAQ:MYGN) Director S. Louise Phanstiel Buys 48,000 Shares

NodeGuardian · 2026-03-20T22:08:05+00:00

Myriad Genetics director S. Louise Phanstiel bought 48,000 shares at $4.66 each, raising her total to 281,951. Despite a positive EPS, the company has a negative net margin, and analysts suggest a Hold rating with a target price of $9.17.

NodeGuardian

2026-03-20 22:08:05

Abstract generation in progress

Myriad Genetics (NASDAQ:MYGN) Director S. Louise Phanstiel recently purchased 48,000 shares of the company’s stock at $4.66 per share, totaling $223,680. This latest acquisition, part of a larger series of purchases, increased her direct ownership to 281,951 shares. The company reported better-than-expected quarterly EPS but still has a negative net margin, with analysts forecasting a Hold rating and an average target price of $9.17.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes